Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04100200 · ClinicalTrials.gov registry record · NA

Berries, Inflammation, and Gut Microbiome

A NA study of Healthy and Overweight or Obesity, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Active
Registry status
NA
Development phase
105
Enrollment target
1
Study location

NCT04100200: Active NA study of Healthy and Overweight or Obesity, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

NCT04100200 is a NA study of Healthy and Overweight or Obesity that is active but no longer recruiting, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 105 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04100200, a NA study of Healthy and Overweight or Obesity, is active but no longer recruiting, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

The primary objectives are to characterize changes in indices of systemic and gut inflammation, assess host- and microbial-derived metabolite pools, and describe and link functional metagenomics and metatranscriptomic alterations in the gut microbiome with metabolite and inflammatory outcomes after acute (24hr) and chronic (4 week) intake of anthocyanins and ellagitannins from strawberry and red raspberries compared to a control diet (negative control), FOS (positive control, non-polyphenol, carbohydrate-based fermentable fiber/pre-biotic), or combination diet (berry composite + FOS) in human participants with low-grade inflammation.

Primary Outcome

Plasma biomarkers and measures of inflammation: Nrf2/ NF-κB activation in monocytes will be analyzed.

Interventions

  • DIETARY_SUPPLEMENT Mixed berries
  • DIETARY_SUPPLEMENT FOS
  • DIETARY_SUPPLEMENT Control
  • DIETARY_SUPPLEMENT Combination

Study Locations (1)

Illinois

  • Clinical Nutrition Research Center - Chicago

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2019-10-07
Est. Completion 2026-01-01
Phase NA

What the registry record for NCT04100200 still lists

NCT04100200 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Mixed berries is the first listed.

NCT04100200 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04100200 about?

NCT04100200 is a clinical study titled "Berries, Inflammation, and Gut Microbiome". The primary objectives are to characterize changes in indices of systemic and gut inflammation, assess host- and microbial-derived metabolite pools, and describe and link functional metagenomics and metatranscriptomic alterations in the gut microbiome with metabolite and inflammatory outcomes after ...

What is the current status of trial NCT04100200?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2019-10-07. Estimated completion is 2026-01-01.

What conditions does trial NCT04100200 study?

This clinical trial studies the following conditions: Healthy, Overweight or Obesity.

What interventions are being tested in trial NCT04100200?

The interventions under investigation include: Mixed berries (DIETARY_SUPPLEMENT), FOS (DIETARY_SUPPLEMENT), Control (DIETARY_SUPPLEMENT), Combination (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04100200?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04100200 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04100200's enrollment target sits among peer trials

105 210th of 1090 higher than 879 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04100200, the US trial registry maintained by the National Library of Medicine. NCT04100200 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.